Filter
9618
Filtered Results: 9618
Text search:
health
strategy
Featured
Recommendations
765
New Publications
2570
Language
Document type
No document type
5447
Studies & Reports
1671
Guidelines
1087
Manuals
440
Strategic & Response Plan
431
Fact sheets
224
Training Material
123
Situation Updates
98
Resource Platforms
34
Infographics
28
Online Courses
16
Brochures
15
Dashboards/Maps
2
App
1
Videos
1
Countries / Regions
Global
403
India
342
Kenya
303
Ethiopia
218
Uganda
204
South Africa
192
Sierra Leone
190
Nepal
188
Liberia
186
Nigeria
179
Myanmar / Burma
171
Western and Central Europe
171
Latin America and the Carribbean
163
Rwanda
150
Indonesia
146
Malawi
146
Africa
145
Zambia
142
Bangladesh
134
Tanzania
126
Syria
124
Ghana
112
Congo, Democratic Republic of
100
Ukraine
97
Philippines
85
Namibia
78
Eastern Europe
76
South Sudan
72
Lesotho
65
Zimbabwe
63
Brazil
61
West and Central Africa
61
Cambodia
60
East and Southern Africa
59
Russia
59
Guinea
58
South–East Asia Region
58
Mozambique
57
Senegal
55
Asia
55
Yemen
50
Haiti
47
Middle East and North Africa
46
Botswana
45
Venezuela
44
Burkina Faso
39
Colombia
39
Cameroon
34
Eastern Europe and Central Asia
34
Pakistan
31
Afghanistan
30
Germany
27
Eswatini/ Swaziland
27
Sudan
26
Benin
25
Jordan
24
Lebanon
24
Mali
21
Somalia
21
Thailand
21
Central African Republic
21
Western Pacific Region
20
Madagascar
19
Peru
18
Vietnam
18
Paraguay
17
Tajikistan
17
USA
15
Iraq
15
Albania
14
Côte d’Ivoire / Ivory Coast
13
China
13
Ecuador
13
Angola
13
Laos
12
Turkey
11
Argentina
11
Chile
11
Moldova
11
Sri Lanka
10
North America
10
Palestine
9
Southern Africa
9
Georgia
9
Niger
8
Burundi
8
Bolivia
8
Libya
8
Guinea-Bissau
7
Togo
7
Egypt
7
Chad
7
North Macedonia
7
Mexico
7
Gambia
6
Papua New Guinea
6
Hungary
6
Timor Leste/ East Timor
6
Iran
6
Honduras
5
El Salvador
5
Kyrgyzstan
5
Kazakhstan
5
Turkmenistan
5
Jamaica
5
Portugal
5
Spain
5
Saudi Arabia
4
Malaysia
4
Greece
4
Guatemala
4
Bhutan
4
Poland
4
Romania
4
Japan
4
Serbia
3
Croatia
3
Italy
3
Armenia
3
Uzbekistan
3
Mauritius
3
Tunisia
3
United Kingdom
3
Bosnia and Herzegovina
3
Morocco
2
Mauritania
2
Singapore
2
Dominican Republic
2
Nicaragua
2
Other region
2
Fiji
2
Djibouti
2
Mongolia
2
Canada
2
Qatar
2
Bulgaria
2
Estonia
2
Lithuania
2
Slovakia
2
Azerbaijan
2
Israel
2
Ireland
1
Vanuatu
1
North Korea
1
Gabon
1
Uruguay
1
Denmark
1
Belgium
1
France
1
Maldives
1
Norway
1
Morocco
1
Belarus
1
Latvia
1
Eritrea
1
Authors & Publishers
Publication Years
Category
Countries
3861
Clinical Guidelines
617
Public Health
549
Women & Child Health
452
Key Resources
429
Capacity Building
164
Pharmacy & Technologies
72
Annual Report MEDBOX
2
General Guidelines
1
Protection & Security
1
Toolboxes
COVID-19
875
HIV
742
Mental Health
581
TB
527
Planetary Health
381
Disability
360
Conflict
291
Ebola
284
AMR
277
Rapid Response
273
NTDs
252
Caregiver
216
NCDs
185
Global Health Education
169
Refugee
144
Natural Hazards
128
Pharmacy
128
Health Financing Toolbox
97
Polio
67
Cholera
62
Zika
57
Specific Hazards
50
Social Ethics
25
Typhoon
8
Health Financing
3
South Sudan
1
Following the high-level meeting of the UN General Assembly on antimicrobial resistance held in September 2016 which called for national, regional and international political commitment to address the issue, member countries agreed on the importance of moving forward to develop national action plans...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middl...
Contact tracing – along with robust testing, isolation and care of cases – is a key strategy for interrupting chains of transmission of SARS-CoV-2 and reducing mortality associated with COVID-19.
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexe...
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and a...
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative ...
The Pandemic Influenza Pandemic (PIP) Framework's Partnership Contribution (PC) High-Level Implementation Plan III (HLIP III) outlines the strategy for strengthening global pandemic influenza preparedness from 2024 to 2030. HLIP III takes into consi...
Prevention offers the greatest public health potential and the most cost-effective long-term cancer control strategy. However, with today’s multiple media streams, the general public is often over...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Mo...
The World Health Organization's Eastern Mediterranean Regional Office (WHO EMRO) highlights the significant health and social consequences of harmful alcohol use. Excessive alcohol consumption is li...
Social protection, a component of the World Health Organization (WHO)’s End TB strategy, has been upheld by Member States as an essential part of the response to tuberculosis in several political ...
Overlapping Pandemics Require U.S. Goverment Leadership
A Report of the CSIS Global Health Policy Center
Part of the series on Tuberculosis
Screening areas, treatment centres and community facilities are part of the strategic priorities for Severe Acute Respiratory Infection (SARI) outbreak preparedness, readiness and response. The SARI Facilities training package has been developed to ...
In October 2021, the ACT-Accelerator (ACT-A) published its 12-month Strategic Plan and budget for the period October 2021 to September 2022. Building on the investment needs outlined in that document, the ACT-A Facilitation Council Financial and Res...
At the threshold of Sustainable Development Goals (SDG) era, this document captures the remarkable achievements by Member States towards achieving MDGs 4 and 5. It acknowledges new opportunities in the post-2015 phase shaped by the SDGs and the Global Str... for women’s, children’s and adolescents’ health and presents an advanced state of preparedness in the Region. This also highlights the region’s renewed commitment for a more inclusive and more dynamic flagship action for ending preventable maternal, newborn and child mortality as well as to improve women’s, children’s and adolescents’ health and wellbeing in the South-East Asia Region.
Nepal has only recently started its journey on the path to an integrated response to the challenge of antimicrobial resistance (AMR). Despite this, it is notable that the Nepal Health Sector Strategy...
This report presents an assessment of the institutional readiness to detect, prevent and address health issues associated with ASGM and aims to provide an input to the Ministry of Health (MISAU) to ...
This guideline for the prevention and control of chikungunya fever
(CF) is intended for use by all peripheral health workers in the Region and
is based on the strategy outlined above. This documen...
With the goal of ending viral hepatitis as a public health threat by 2030, the Regional Action Plan will provide an actionable framework for implementing evidence-based interventions at scale. It will be informed through ...ic monitoring of the response, that must be equitable and sustainable and allow for innovations for acceleration and reaching out to all in need with health services. A major reduction in prices of newer drugs to potentially cure hepatitis C offers an added opportunity to work towards its elimination.
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide ...ic guidance as to WHO’s preferences for new vaccines in priority disease areas. PPCs are intended to encourage innovation and development of vaccines for use in settings most relevant to the global unmet public health need.
Gonococcal vaccine PPCs describe global public health goals for gonococcal vaccines and preferred parameters pertaining to vaccine indications and target populations, safety and efficacy considerations, and immunization strategies.
